Cyto-immuno-therapy for Cancer: a pathway elicited by tumor-targeted, cytotoxic drug-packaged bacterially derived nanocells

Immunotherapy has emerged as a powerful new chapter in the fight against cancer. However, it has yet to reach its full potential due in part to the complexity of the cancer immune response. We demonstrate that tumor-targeting EDV nanocells function as an immunotherapeutic by delivering a cytotoxin i...

Full description

Autores:

Sagnella, Sharon M.
Yang, Lu
Stubbs, Gemma E.
Boslem, Ebru
Martino-Echarri, Estefania
Smolarczyk, Katarzyna
Pattison, Stacey L.
Vanegas, Natasha
St Clair, Eva
Clarke, Stephen
Boockvar, John
MacDiarmid, Jennifer A.
Brahmbhatt, Himanshu

Tipo de recurso:

Article of journal

Fecha de publicación:

2020

Institución:

Universidad El Bosque

Repositorio:

Repositorio U. El Bosque

Idioma:

eng

OAI Identifier:

oai:repositorio.unbosque.edu.co:20.500.12495/9250

Acceso en línea:

http://hdl.handle.net/20.500.12495/9250
https://doi.org/10.1016/j.ccell.2020.02.001

Palabra clave:

Cáncer
Terapia combinada
Citoinmunoterapia
Inmunoterapia
Nanocélulas
Supercitotoxina
Objetivo del tumor
PNU-159682
Cancer
Combined therapeutic
Cyto-immunotherapy
Immunotherapy
Nanocell
Supercytotoxin
Tumor targeting

Rights

closedAccess

License

http://purl.org/coar/access_right/c_14cb